Home > Financial Ratios > ALBERT DAVID

ALBERT DAVID
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for ALBERT DAVID
Please provide your vote to see the results

ALBERT DAVID Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 74.625.4555.72-3.07-25.87

What is the latest Core EBITDA Growth ratio of ALBERT DAVID ?

The latest Core EBITDA Growth ratio of ALBERT DAVID is 74.62 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar202474.62
Mar20235.45
Mar202255.72
Mar2021-3.07
Mar2020-25.87

How is Core EBITDA Growth of ALBERT DAVID Trending?

Years Core EBITDA Growth % Change
Mar2024 74.62
1,269.17
Mar2023 5.45
-90.22
Mar2022 55.72
Positive
Mar2021 -3.07
Negative
Mar2020 -25.87 -

Other Financial Ratios of ALBERT DAVID


Compare Core EBITDA Growth ratio of peers of ALBERT DAVID

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
ALBERT DAVID ₹484.7 Cr 6.4% -5.5% -22.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹405,068.0 Cr 1.4% 0.1% 13.9% Stock Analytics
DIVIS LABORATORIES ₹177,105.0 Cr 0.8% 12.3% 47.2% Stock Analytics
CIPLA ₹122,016.0 Cr 2.6% -0.1% 0.6% Stock Analytics
DR REDDYS LABORATORIES ₹112,651.0 Cr 7.8% 12.9% 13.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹108,942.0 Cr 2.7% -0.6% 14.4% Stock Analytics


ALBERT DAVID Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
ALBERT DAVID

6.4%

-5.5%

-22.6%

SENSEX

2.1%

3.7%

14.3%


You may also like the below Video Courses